House Energy & Commerce To Continue Foraging Through Vytorin Data
Executive Summary
The House Energy & Commerce Committee intends to keep hounding Merck and Schering-Plough for data and internal communications on how the company handled the release of information from three trials on Vytorin (simvastatin/ezetimibe)
You may also be interested in...
IRB Problems Will Increase Congressional Pressure On Industry Trial Designs
Congress may be looking to limit the flexibility that firms have in conducting clinical trials following a study that revealed operational shortcomings in the conduct and registration of Institutional Review Boards
IRB Problems Will Increase Congressional Pressure On Industry Trial Designs
Congress may be looking to limit the flexibility that firms have in conducting clinical trials following a study that revealed operational shortcomings in the conduct and registration of Institutional Review Boards
IRBs To Be Subject Of House Hearing After “Congressional Sting Operation”
CEO of Coast Institutional Review Board, which approved an imaginary study, will testify before Rep. Stupak’s subcommittee.